🔗 Share this article

An underground economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to contact these accounts privately for supplier links, while also obtaining promotional offers.

Active Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and assertions of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Professionals Express Concerns

Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could lead to users administering products of uncertain source.

Some experts said the demand for retatrutide could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be marketed or distributed for human use under the British medical regulations.

Some content creators try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, risking fines, prosecution or imprisonment.

Service Reaction and Content Elimination

Based on TikTok, the service has removed problematic content and banned related hashtags and search suggestions. The organization said it was committed to maintaining the service safe and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Research also discovered groups with up to 9,000 members marketing the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, populated with images of weight loss, glowing reviews and step-by-step instructions for mixing or administering at residence.

After minutes of entering one group, a vendor posted contact information, where the majority of transactions occur. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about weight, health issues or past usage.

Product Information and Pricing

Within these communities, posts display dark colored packages with Royal Mail stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Oversight and Safety Actions

A representative for the messaging service stated it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering substances they cannot confirm. Although the research behind retatrutide is sound, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her team has previously seen patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may subject users to potentially significant health risks”.